VC  Foundation Venture Capital Group

http://www.foundationventure.com





     Office Locations:

120 Albany Street, Tower II, Suite 850
New Brunswick, NJ 08901

 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    Foundation Venture Capital Group, established in March 2006 as an independent organization, invests exclusively in research at the University of Medicine and Dentistry of New Jersey (UMDNJ) by funding new life science companies. The Foundation Venture Capital Group was initially funded by the New Jersey Health Foundation with $5 million to invest. The corporation collaborates with the Office of Patents and Licensing at the University of Medicine and Dentistry of New Jersey to provide support and opportunities for University researchers by using private equity investments to make early stage investments in life science companies that license UMDNJ technology. Once a company is established with seed funding, Foundation Venture Capital Group will seek to work with other traditional venture capital companies to help advance these technologies.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Aggie Worthington Vice President
    Dale R. Heffler Vice President
    George F. Heinrich MD Vice Chair and CEO
    James M. Golubieski President
    Michael Wiley Director

     

    Portfolio companies include:


      Actinobac Biomed
        web link


      Affineti Biologics
        web link


      CellXplore
        web link


      Celvive
        web link


      Durin Technologies
        web link


      Longevica
        web link


      MentiNova
        web link


      NovoPedics


      Snowdon Pharmaceuticals
        web link


     

    Recent News: